26 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
2013 Request for Proposals for Grants Related to Pediatric Mast Cell Disorders (Pediatric Mastocytosis and Pediatric Mast Cell Activation Syndrome)
The Mastocytosis Society, Inc. (TMS) and Mastokids (MKO) are pleased to announce that we are accepting proposals for research grants for new or ongoing projects related to Pediatric Mastocytosis or Pediatric Mast Cell Activation Syndrome.
An amount of $60,000 is available for this grant.
Submission deadline: Proposals must be received by June 1, 2013
Request for Proposals: Funding Opportunities for Kennedy’s Disease Research
The Kennedy’s Disease Association (KDA) is planning to fund one or more research grants this fall to further the understanding of the pathological mechanisms of Kennedy’s Disease.
The KDA projects that funding for each grant will be up to $25,000.
Applications from junior investigators and from senior post-doctoral fellows are encouraged.
Your proposals must be received by Friday, June 21, 2013.
Cystinosis Foundation Deanna Lynn Potts Scholarship
Deanna Lynn Potts was born with Cystinosis and lived to be 27 years old. Before she died, she discussed her wishes to start a scholarship fund for children with Cystinosis.
We know how devastating a chronic illness can have on a family emotionally, physically, socially, and financially. Children with Cystinosis are living longer, thanks to medical science and therefore, embarking on careers.
These careers require education. Education is expensive, yet something we do not want to deprive our children of in our world today. Due to the financially draining medical costs, it might prove difficult to send a child to college.
Through this fund, we hope to help some of those students.
PURPOSE: To provide supplemental financial assistance to an undergraduate student diagnosed with Cystinosis enrolled in an accredited collegiate or vocational program.
SCHOLARSHIP AWARD: A $1000 scholarship awarded annually. The award is contingent upon the winners acceptance to an accredited college, university, or vocational program and will be payable to the education institution to be applied to tuition, room and board.
ELIGIBILITY: Each candidate must be a current high school senior, who has Cystinosis and have a financial need.
APPLICATION PROCEDURE:
Documentation/verification of Cystinosis (e.g. letter from physician.)
An official copy of high school transcript.
Two letters of recommendation from current teachers/faculty members and/or counselors regarding applicant's scholastic aptitude and personal qualifications.
An essay of 500 words. We want to know a person who has played a vital role in student's life. How? Why? The essay should be typewritten and double spaced
A copy of the previous year's income tax return.
JUDGING CRITERIA: The essay will earn a possible 40 points and will be judged on the basis of rationale, grammar and comprehension. Transcripts and letters of recommendation will carry a possible additional 20 points. The Cystinosis Foundation Board will establish an independent judging panel to evaluate and rate the applicants. The decision of the judges is final. Finalists may be interviewed before selection is made.
DEADLINE FOR APPLICATION: Application and all accompanying documents must be received at the Cystinosis Foundation Office in a single, flat package by March 30th of each year. You can call the Cystinosis Foundation for an application 888-631-1588.
Remember, the deadline for receiving applications is March 30th of each year.
Call for Research Grant Applications: Cicatricial Alopecia Research Foundation
The Cicatricial Alopecia Research Foundation (CARF) seeks original, focused, and innovative research grant applications dealing with primary cicatricial alopecia (PCA). Applications will be accepted from laboratories around the world. The proposed project must serve to further CARF's research goals, namely, to understand the pathogenesis of PCA, an understanding that will lead to effective prevention and therapy. CARF will give priority to research proposals based on the following topics.
Role of lipids and lipid metabolism in normal hair follicle stem cell biology and cycling
Role of PPARs and other lipid regulators in the pathogenesis of PCA
Role of peroxisomes in hair follicle biology
Role of neuroinflammation in PCA
Role of environmental triggers in the pathogenesis of PCA
Function of sebaceous glands in normal hair follicle biology.
Mechanism of hair shaft egress from the terminal hair follicle
Hair follicle regeneration in a site of tissue repair
GUIDELINES: All applications for grant requests should clearly state research goals, rationale, brief background, and brief experimental protocol. The planned study may not exceed two years in duration. Included in the submission should be a discussion of anticipated results and their potential significance to understanding PCA. Typical awards are $5,000 to $20,000.
A final progress report must be submitted at the end of the funding period. A progress report must be submitted at the end of the first year to obtain a second year no-cost extension. CARF must be acknowledged on all presentations and publications resulting from CARF funded grants.
Applications are reviewed and funded on an annual basis.
Annual application deadline: March 15. Funding decisions made by June 15.
ALS Therapy Alliance Grants Program
Thank you for your interest in submitting a proposal for grant funding to the ALS Therapy Alliance (ATA). Our organization traditionally awards grants from one to three years in term ranging from $100,000 to $1 million in funding to both non- and for-profit companies. National and international companies are eligible to apply.
The following outline will help you prepare the information needed for our next funding review, which happens twice a year in April and November.
Please note grant submission deadlines and number of copies requested in order to ensure timely processing of your application. The ALS Therapy Alliance does not cover indirect costs.
If you have questions about the submission process or this application, please contact Ray Bisson, Grants Manager at (603) 664-5005 or ray@alstherapyalliance.org, or visit our FAQ page.
http://alstherapyalliance.org/index.php/research/grant-submission-process/faqs.html
What to include with your grant proposal
ATA grant applications should follow the following format and adhere strictly to the maximum page limits (using only 11 point font or greater):
■ Abstract (1 page)
■ Background and Significance (2 pages)
■ Preliminary Data (2 pages)
■ Experimental Plan (3 pages)
■ References (no limit)
■ Budget
■ Budget Justification
■ NIH Biosketch (including present and pending support, 4 pages maximum) for PI's, post-docs and others involved in the project (excluding laboratory technicians)
■ Letters of collaboration and support
Grant proposal submission deadlines
To have your grant proposal reviewed at our April meeting, please submit by March 15th. To have your grant proposal reviewed at our November meeting, please submit by October 15th.
Where to send your grant proposal
Please email your proposal in PDF format to ray@alstherapyalliance.org.
Call for Applications: Meso Foundation Research Grants
The Meso Foundation (formerly known as MARF) is the non-profit dedicated to ending the suffering caused by mesothelioma. We are the international collaboration of patients and families, physicians, advocates, and researchers dedicated to eradicating the life-ending and vicious effects of mesothelioma. We believe in a cure for meso. Given the human toll of suffering the disease causes, the compassion and energy of the meso community, the moral, legal and economic aspects of asbestos, and the benefits of meso research to cancer research generally, we believe that the resources to accomplish this cure are available and must be mobilized. We seek to marshal and utilize these resources responsibly, as effectively as possible, with financial transparency and by adhering to health policy guidelines that foster ethical clinical and administrative practices, and ethical decision making to:
· Offer hope and support to patients and families by educating them on the disease, helping them to obtain the most up-to-date information on treatment options and to connect with meso treatment specialists, and providing them assistance, emotional support and community with others;
· Raise awareness of meso, and advocate that the public and private sectors partner in the effort to cure it by directing the resources needed to stop this global tragedy; and
· Fund the highest quality and most promising meso research projects from around the world through rigorous peer-review. To date we have funded 86 projects, from six different countries, totaling over 8.2 million dollars.
The Meso Foundation offers research grants for two years up to $50,000 per year. Eligible projects may relate to benchwork, translational or clinical research that is not presently funded or pending review and may be conducted through any not-for-profit academic, medical or research institution. The Foundation will review and monitor the project's progress and results, requiring semi-annual disposition of funds reports, a ten month progress report, a presentation at the Foundation’s Symposium and a full progress report at the close of the project. The Foundation seeks exceptional projects for which the Foundation's funding is demonstrated to be essential and not duplicative. Please be advised that the Foundation does not pay institutional indirect costs.
Funded researchers will also be entitled to facilitated access to the National Mesothelioma Virtual Bank (NMVB),www.mesotissue.org.They will receive expedited review of requests to use the NMVB, and they will have direct, no-cost access to materials in the bank, as well as enhanced collections from the main sites of materials.
Encouraged projects include, but are not limited to, investigations of:
1. Strategies for early detection of new or progressive disease;
2. Definition of targetable differences between normal and transformed mesothelium and development of novel strategies for treatment;
3. Therapeutic intervention, including but not limited to;
a. Immune Response Targeted Therapy
b. Novel chemotherapeutic compounds
c. Novel radiation or surgical techniques
4. Determination of clinical/molecular determinants for prognosis
Applications will be considered for funding by the Meso Foundation’s Science Advisory Board comprised of doctors and researchers who work around the world within the mesothelioma field. These members will review and score the research proposals based on the following criteria. The applications will be ranked numerically and the highest scoring projects will be recommended to the Foundation’s Board of Directors for funding. Based on the funding available, awards will be granted.
Applications will be evaluated on the following criteria:
Significance - Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Investigator(s)- Are the PD/PIs, collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
Innovation - Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Approach - Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, justified in terms of the scientific goals and research strategy proposed?
Environment - Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
Applications should be submittedthrough proposalCENTRAL.You will find the Mesothelioma Applied Research Foundation listed with the instructions and the application required. Applications are limited to 10 pages (not including biographies) and are due no later than August 2, 2013. Final award decisions will be made in December 2013 and all applicants will be notified of the outcome.
Gilead Sciences Research Scholars Program in Cystic Fibrosis
Application Deadline: July 26, 2013
The mission of the Gilead Sciences Research Scholars Program in Cystic Fibrosis is to support innovative scientific research that will advance knowledge in the fields of pediatric and adult cystic fibrosis and provide support for early research career development. Gilead Sciences, Inc. hopes that the research supported by these awards will enhance understanding of cystic fibrosis.
The Program provides financial support to 3 junior faculty researchers for a 2-year period. Each award is funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years. Funding for the second year is contingent upon submission of a progress report and approval by the Scientific Review Committee Chair.
Recipients of these competitive awards will be selected by a Committee comprised of leaders in the field of cystic fibrosis (the "Scientific Review Committee" or the "Committee"). The Committee will review complete applications and select research proposals based on their scientific merit, feasibility, mentorship, environment, and candidate. Announcement of award recipients will be made at an awards dinner hosted by the Committee and senior representatives from Gilead.
Applicants must meet the eligibility criteria in order to be considered for an award.
Eligibility
This award is intended for junior faculty who are in the early stages of their career; specifically, the Applicant may be the recipient of a career development (K) award, or another mentored research award, but not an RO1 grant or equivalent.
Applicants must meet the following requirements:
Hold an MD, DO, PhD, or equivalent degree at time of award
Be within 7 years of a faculty appointment, or an assistant professor, in association with a research institution in the United States at the time of application
Have a strong career interest in cystic fibrosis
Have a research mentor with extensive experience in the field of cystic fibrosis
Be able to devote at least 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)
Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects
Citizenship
An Applicant must be a citizen or permanent resident of the United States or hold a temporary nonimmigrant visa. This visa must be valid for the two-year award period (January 2, 2014 – December 31, 2015).
For general inquires about the Research Scholars Program, please call or email:
Attn: Research Scholars Program Coordinator
Telephone: 646-674-1820 Email: cfresearchscholars@contacthmc.com
If you are experiencing technical difficulties, please contact Zoomedia at 901-210-9564. If you have any other questions, please contact the Research Scholars Program Coordinator at 646-474-1820.
Children's Fund for Glycogen Storage Disease Research Grants Program
The Children's Fund for Glycogen Storage Disease Research accepts grant applications that relate to GSD1 research, diagnosis, and/or patient care. Grant application forms are available by request. Submissions should be via email only. You may contact our foundation by emailing us at info@curegsd.org or by phoning (203) 272-CURE (2873).
Annual Deadlines:
June 30...Deadline for proposal submission
July 30...Board to meet regarding grants/fellowships awarded
August 15...Notification letters sent
August 30...Grant/fellowship monies disbursed
Request for Application: A-T Children's Project
Attention Researchers:
Request for Application (RFA) for March 1, 2013 and September 1, 2013
Seed funding is now available for innovative proposals that seek to identify and validate biomarkers of A-T disease progression and that can be used to monitor therapeutic efficacy in clinical trials.
Please note that investigator-initiated proposals are also welcome for the March 1 and September 1 grant submission deadlines; however priority will be given to proposals that address the above referenced RFA.
We welcome investigators to contact Cynthia Rothblum-Oviatt, PhD, our Science Coordinator, if help is needed forming collaborations and/or obtaining reagents for A-T/ATM research.
Cynthia Rothblum-Oviatt, PhD Science Coordinator A-T Children's Project 5300 W. Hillsboro Blvd., Suite 105 Coconut Creek, FL 33073 cynthia@atcp.org Phone: 703-765-1223
123next
